chandrashekar Thalluri

chandrashekar Thalluri

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2023 in Acta Chimica Slovenica
Verified
Journal Article
Open access
PDF file
CTchandrashekar Thalluri
chandrashekar Thalluri
KSKalpana Swain
Kalpana Swain
SPSatyanarayan Pattnaik
Satyanarayan Pattnaik
Nanoparticles are typically nanoscopic materials with at least one of the dimensions below 100 nm having diverse applications in many industries. The latest developments in nanotechnology provide a wide range of methods for studying and monitoring various medical and biological processes at the nanoscale. Nanoparticles can help diagnose and treat diseases, such as cancer, by carrying drugs directly to cancer cells. They can also be used to detect disease biomarkers in the body, helping to provide early diagnosis. It is plausible that nanoparticles could be used in theranostic applications and targeted drug delivery. This could significantly improve patient outcomes and reduce the amount of time, effort, and money needed to diagnose and treat diseases. It could also reduce the side effects of treatments, providing more precise and effective treatments. Nanoparticles for biomedical applications include polymeric and metal nanoparticles; liposomes and micelles; dendrimers and quantum dots; etc. Among the nanoparticles, gold nanoparticles (GNPs) have emerged as a promising platform for drug delivery applications. GNPs are highly advantageous for drug delivery applications due to their excellent biocompatibility, stability, and tunable physical and chemical properties. The present review provides an in-depth discussion of the various approaches to GNPs synthesis and drug delivery applications.

27 May 2025 in Discover Applied Sciences
Verified
Journal Article
Open access
PDF file
LDLakshman Kumar Dogiparthi
Lakshman Kumar Dogiparthi
SBSarad Pawar Naik Bukke
Sarad Pawar Naik Bukke
CTchandrashekar Thalluri
chandrashekar Thalluri
BTBalakrishna Thalamanchi
Balakrishna Thalamanchi
KVK. P. Vidya
K. P. Vidya
KTKusuma Priya Thummaginjala
Kusuma Priya Thummaginjala
The Genomic and proteomics have transformed drug development, enabling precision medicine and targeted medicines. Genomics allows the detection of genetic variants and mutations that affect illness susceptibility and therapeutic response, enabling personalised treatments. Proteomics complements this by elucidating protein structures, functions, and interactions, providing insights into disease pathways and potential therapeutic targets. This review explores the synergistic integration of genomics and proteomics in drug discovery, highlighting cutting-edge tools like CRISPR-Cas9, next-generation sequencing (NGS), protein associated with genome editing, and mass spectrometry-based proteomics. Applications in pharmacy include the identification of biomarkers for drug efficacy and safety, the drug delivery optimization, and the innovation of novel therapeutics for complex diseases. Despite significant progress, challenges such as data integration, ethical considerations, and the high cost of technologies persist. The development of robust bioinformatics tools, collaborative research, and regulatory frameworks shows a key role in translating genomic and proteomic data into clinical practice. These advancements underscore the transformative potential of novel approaches in revolutionizing drug discovery and enhancing patient-centered care in pharmacy, paving the way for innovative therapeutics and improved healthcare outcomes. Graphical abstract

2 December 2025 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
PDF file
JMJharna Medhi
Jharna Medhi
CTchandrashekar Thalluri
chandrashekar Thalluri
MVMallikarjun Vasam
Mallikarjun Vasam
SBSarad Pawar Naik Bukke
Sarad Pawar Naik Bukke
Transferosomes represent a novel vesicular drug delivery system developed to overcome the limitations of traditional transdermal systems. These ultra-defor

1 July 2024 in International Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
KSKoushik Narayan Sarma
Koushik Narayan Sarma
CTchandrashekar Thalluri
chandrashekar Thalluri
JMJithendar Reddy Mandhadi
Jithendar Reddy Mandhadi
Pharmaceutical formulations, polymer-based nanofibers, which have higher surface area per unit mass of solid, enable and contribute to functions linked to surface shape. Nanofibers can be made using a number of different methods, but only electrospinning technology has been specifically focused on producing a wide variety of these common polymer-based nanofibers. The manufacturing potential of just this method is enormous. Electrospinning is also the most versatile, as it can produce a wide range of nanowire assemblies that, with the right tweaks, might improve the performance of goods made from Nanofibers. For these reasons, it is crucial and necessary to study the many factors and procedures that go into making the best possible nanofibers. Standard processes and tools may be used to examine nanofibers’ structure, morphology, and geometry, as well as their tensile and elongation characteristics. In this article, we take a look at the various ways in which polymer composite nanofibers can be used in tissue engineering, such as in tissue scaffolds and cutting-edge wound dressings for chronic wound therapy, in addition to their potential roles in drug delivery systems, in clothing protectors, and sensors. There are just a select few of these products that have been released so far, but more nano- and bio-sciences products are expected to hit the market shortly. Polymer-based nanofibers have emerged as a result of efforts to commercialize these applications. A variety of fields, including biology, nutrition, bioengineering, pharmaceuticals, and healthcare, find this structured fiber useful.

16 December 2025 in Materials Technology
Verified
Journal Article
Open access
CTchandrashekar Thalluri
chandrashekar Thalluri
SBSarad Pawar Naik Bukke
Sarad Pawar Naik Bukke
MVMallikarjun Vasam
Mallikarjun Vasam
YNYenumula Nettikallu
Yenumula Nettikallu
MMMuhamad Mustafa Mundu
Muhamad Mustafa Mundu

15 April 2023 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
KSKumara Swamy Samanthula
Kumara Swamy Samanthula
DKDurgaprasad Kemisetti
Durgaprasad Kemisetti
JMJithendar Reddy Mandhadi
Jithendar Reddy Mandhadi
CTchandrashekar Thalluri
chandrashekar Thalluri
BDBiplab Kumar Dey
Biplab Kumar Dey
Hot melt extrusion (HME) technology was introduced to pharmaceuticals in the 1970s for manufacturing and product development. Since then, there were several developments in HME technology to utilize it effectively for the manufacturing of pharmaceuticals. Though the primary purpose of HME technology remains to be solubility enhancement through the preparation of amorphous solid dispersions, it also has various other applications like dry granulation, abuse-deterrent formulation, continuous manufacturing, film preparation, implants, sustained release formulations, etc. The purpose of this review article is to consolidate the information related to applications of HME technology in the pharmaceutical industry. Keywords: Hot melt extrusion, poorly soluble drugs, continuous manufacturing, solid orals, and applications.